Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Perinatol. 2013 May;30(5):347-52. doi: 10.1055/s-0032-1326985. Epub 2012 Sep 21.

The role of novel biomarkers in early diagnosis and prognosis of acute kidney injury in newborns.

Author information

1
National and Kapodistrian University of Athens, Medical School, Athens, Greece.

Abstract

Acute kidney injury (AKI) refers to the rapid loss of renal function. In clinical practice, AKI is common among hospitalized patients of all age groups including neonates and remains an important cause of morbidity and mortality due to its late diagnosis and therefore delayed therapeutic intervention. Although the precise incidence of AKI in newborn is unknown, several studies have reported that 8 to 24% of all critically ill newborns in neonatal intensive care units may develop the condition. We aim at reviewing the existing literature on novel serum and urinary biomarkers and discuss their role in the early diagnosis and prognosis of AKI in newborns. Specifically, this review will focus on cystatin C (CysC), neutrophil gelatinase-associated lipocalin (NGAL) and interleukin-18 (IL-18) in serum and on CysC, NGAL, kidney injury molecule-1, and IL-18 in urine.

PMID:
23023560
DOI:
10.1055/s-0032-1326985
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Georg Thieme Verlag Stuttgart, New York
    Loading ...
    Support Center